| Discovery of a Chiral DNA‐Targeted Platinum–Acridine Agent with Potent Enantioselective Anticancer Activity S Zhang, X Yao, NH Watkins, PK Rose, SR Caruso, CS Day, U Bierbach Angewandte Chemie International Edition 59 (49), 21965-21970, 2020 | 13 | 2020 |
| Effect of the nonleaving groups on the cellular uptake and cytotoxicity of platinum-acridine anticancer agents PK Rose, NH Watkins, X Yao, S Zhang, IY Mancera-Ortiz, JT Sloop, ... Inorganica Chimica Acta 492, 150-155, 2019 | 9 | 2019 |
| Development of Prodrug–Payloads for Targeted Therapeutic Applications of Platinum–Acridine Anticancer Agents IY Mancera-Ortiz, J Chen, TA Slade, X Yao, S Zhang, CS Day, U Bierbach Bioconjugate Chemistry 34 (10), 1873-1881, 2023 | 1 | 2023 |
| Platinum–Acridine Agents with High Activity in Cancers Expressing the Solute Carrier MATE1 (SLC47A1) S Zhang, H Wu, CS Day, U Bierbach ACS Medicinal Chemistry Letters 14 (8), 1122-1128, 2023 | | 2023 |
| Platinum-acridine compounds and methods of treating cancers U Bierbach, S Zhang, X Yao, IY Mancera-Ortiz, NH Watkins US Patent App. 17/235,382, 2021 | | 2021 |
